一名慢性淋巴细胞白血病患者在新型冠状病毒肺炎轻症期间外周血中CD19/CD5 B淋巴细胞克隆短暂消失
Transient disappearance of CD19/CD5 B-lymphocyte clone in peripheral blood in a patient with CLL during SARS-CoV-2-related mild disease.
作者信息
Barnabei Remo, Di Michele Giulio, Cellini Antonio, Amicosante Gianfranco, Perilli Mariagrazia, Bellio Pierangelo, Piccirilli Alessandra, Celenza Giuseppe
机构信息
Clinical Laboratory Regional Hospital "San Salvatore" L'Aquila Italy.
Department of Infectious Diseases and AIDS Regional Hospital "San Salvatore" L'Aquila Italy.
出版信息
Clin Case Rep. 2021 Jun 22;9(6):e04238. doi: 10.1002/ccr3.4238. eCollection 2021 Jun.
Abstract
Although lymphopenia is currently considered a good predictor for the prognosis of COVID-19, it must be critically evaluated in patients with CLL, where other clinical markers should be considered to define the prognosis and treatment.
摘要
尽管淋巴细胞减少目前被认为是COVID-19预后的良好预测指标，但对于慢性淋巴细胞白血病（CLL）患者，必须进行严格评估，在这类患者中，应考虑其他临床标志物来确定预后和治疗方案。
Zotero 插件